- Home
- OGN vs ARWR Comparison
OGN vs ARWR Comparison
Compare OGN & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGN
- ARWR
- Stock Information
- Founded
- OGN 1923
- ARWR 2003
- Country
- OGN United States
- ARWR United States
- Employees
- OGN N/A
- ARWR N/A
- Industry
- OGN Biotechnology: Pharmaceutical Preparations
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- OGN Health Care
- ARWR Health Care
- Exchange
- OGN Nasdaq
- ARWR Nasdaq
- Market Cap
- OGN 2.7B
- ARWR 2.5B
- IPO Year
- OGN N/A
- ARWR 1993
- Fundamental
- Price
- OGN $10.25
- ARWR $36.64
- Analyst Decision
- OGN Buy
- ARWR Strong Buy
- Analyst Count
- OGN 3
- ARWR 8
- Target Price
- OGN $17.33
- ARWR $47.75
- AVG Volume (30 Days)
- OGN 3.6M
- ARWR 2.4M
- Earning Date
- OGN 10-30-2025
- ARWR 11-25-2025
- Dividend Yield
- OGN 0.78%
- ARWR N/A
- EPS Growth
- OGN N/A
- ARWR N/A
- EPS
- OGN 2.69
- ARWR N/A
- Revenue
- OGN $6,281,000,000.00
- ARWR $572,976,000.00
- Revenue This Year
- OGN N/A
- ARWR $21,421.26
- Revenue Next Year
- OGN $0.79
- ARWR N/A
- P/E Ratio
- OGN $3.82
- ARWR N/A
- Revenue Growth
- OGN N/A
- ARWR 2816.20
- 52 Week Low
- OGN $8.01
- ARWR $9.57
- 52 Week High
- OGN $19.05
- ARWR $39.42
- Technical
- Relative Strength Index (RSI)
- OGN 56.23
- ARWR 73.44
- Support Level
- OGN $10.52
- ARWR $36.29
- Resistance Level
- OGN $11.29
- ARWR $39.38
- Average True Range (ATR)
- OGN 0.32
- ARWR 1.39
- MACD
- OGN -0.01
- ARWR 0.06
- Stochastic Oscillator
- OGN 51.37
- ARWR 69.44
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.